Substance Name: Cosfroviximab [USAN]
RN: 1792982-57-0
UNII: 820CI2BHRP
Molecular Formula
- C6448-H9962-N1706-O2022-S42 (peptide)
Classification Code
- Treatment of Ebola Virus
* denotes mobile formatted website
Links to Resources
Names and Synonyms
Name of Substance
- Cosfroviximab [USAN]
Synonyms
- c13C6-FR1
- Cosfroviximab
- Immunoglobulin G1-kappa, anti-(Ebolavirus/Reston ebolavirus/Sudan ebolavirus/Tai Forest ebolavirus glycoprotein); chimeric Homo sapiens-Mus musculus monoclonal antibody: gamma1 heavy chain (1-452) (Mus musculus VH (IGHV8-8*01 (77%) -(IGHD)-IGHJ4*01 (93%)) (10.7.14) (1-122) -Homo sapiens IGHG1*01(CH1 K97>R(219)) (123-452)) (225-213')-disulfide with kappa light chain (1'-213') (Mus musculus V-kappa (IGKV6-13*01 (95%) -IGKJ5*01) (6.3.9) (1'-106') -Homo sapiens IGKC*01 (107'-213')) dimer (231-231'':234-234'')-bisdisulfide STRUCTURAL FORMULA
- UNII-820CI2BHRP
Systematic Name
- Immunoglobulin G1, anti-(Ebolavirus/Reston ebolavirus/Sudan ebolavirus/Tai Forest ebolavirus glycoprotein) (human-Mus musculus monoclonal c13C6-FR1 heavy chain), disulfide with human-Mus musculus monoclonal c13C6-FR1 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 1792982-57-0
FDA UNII
- 820CI2BHRP
System Generated Number
- 1792982570